Table 1.
Characteristics of the InCHIANTI study population at baseline (left) and limited to participants who were also evaluated at the three-year follow-up (right)
| Baseline population (n = 1260) | Follow-up population (n = 827) | |||||||
|---|---|---|---|---|---|---|---|---|
| Men | Women | Correlation coefficient with NCVa | Correlation coefficient with CMAPa | Men | Women | Correlation coefficient with NCVb | Correlation coefficient with CMAPb | |
| BMI (kg/m2) | 27.1 (3.4) | 27.2 (4.6) | 0.138* | 0.021 | 27.1 (3.2) | 27.2 (4.5) | 0.114* | −0.012 |
| Height (cm) | 177.7 (93.1) | 163.1 (85.6) | −0.025 | −0.056 | 169.9 (43.1) | 158.6 (58.4) | −0.038 | −0.051 |
| Energy intake (kcal/day) | 2290 (608) | 1806 (525) | 0.011 | 0.039 | 2357 (588) | 1839 (535) | 0.009 | 0.063 |
| Alcohol intake (g/day) | 24.0 (19.2) | 9.6 (7.5) | 0.017 | −0.004 | 24.8 (18.7) | 9.7 (7.6) | 0.020 | −0.032 |
| Total cholesterol (mg/dl) | 208.0 (39.3) | 222.7 (39.4) | 0.092* | 0.068** | 209.5 (37.1) | 225.5 (40.0) | 0.094** | 0.042 |
| HDL Cholestrol (mg/dl) | 51.4 (13.0) | 59.8 (15.3) | −0.008 | 0.012 | 52.3 (13.1) | 59.3 (14.6) | −0.008 | −0.002 |
| Tryglycerides (mg/dl) | 131.5 (88.8) | 120.6 (64.7) | 0.068** | 0.044 | 129.4 (72.9) | 120.1 (63.6) | 0.090* | −0.012 |
| Diabetes (n,%) | 65 (11.5) | 64 (9.2) | −0.081** | −0.095* | 37 (9.6) | 37 (8.4) | −0.029* | −0.092** |
| PAD (n, %) | 83 (14.7) | 71 (10.2) | −0.187* | −0.008 | 44 (11.5) | 38 (8.6) | −0.087** | −0.038 |
a
Partial correlation coefficient, adjusted for age and sex;
b
Partial correlation coefficient, adjusted for age- sex- and baseline NCV and baseline CMAP, respectively.
*
P < 0.01;
**
P < 0.05.
BMI, body mass index; CMAP, compound muscle action potential; HDL, high-density lipid; NCV, nerve conduction velocity; PAD, peripheral artery disease.